Michelle Halpain

Title: Michelle Halpain: Innovator in Enzymatic Synthesis of Oligonucleotides

Introduction

Michelle Halpain is a prominent inventor based in Stanford, CA (US). She has made significant contributions to the field of biotechnology, particularly in the enzymatic synthesis of oligonucleotides. Her innovative work has the potential to advance various applications in genetic research and therapeutic development.

Latest Patents

Michelle Halpain holds a patent for a "Method and system for enzymatic synthesis of oligonucleotides." This patent describes methods, processes, and systems for synthesizing oligonucleotides from a single-stranded, immobilized primer in the presence of a polymerase. The disclosed methods allow for the enzymatic synthesis of single-stranded oligonucleotides using deoxyribonucleotide triphosphates or ribonucleotide triphosphates. Additionally, the method enables the addition of dideoxyribonucleotide triphosphates and other terminators to the primer or its extension products.

Career Highlights

Throughout her career, Michelle has demonstrated a strong commitment to innovation in biotechnology. Her work at Centrillion Technology Holdings Corporation has positioned her as a key player in the development of advanced oligonucleotide synthesis techniques.

Collaborations

Michelle collaborates with talented individuals in her field, including Kendall Hoff and Wei Zhou. Their combined expertise contributes to the advancement of research and development in enzymatic synthesis.

Conclusion

Michelle Halpain's contributions to the field of oligonucleotide synthesis exemplify the impact of innovative thinking in biotechnology. Her patent and ongoing work continue to pave the way for future advancements in genetic research and therapeutic applications.